Walgreens Boots Alliance Inc (WBA) Stock Price, News & Historical Data - TheStreet

Summary

Profile

Financials

Events

Ownership

Options

Symbol	Last	Change
WBA	54.30	0.00 (0.00%)
COST	502.99	0.00 (0.00%)
LOW	243.40	0.00 (0.00%)
CVS	106.22	0.00 (0.00%)
JD	73.72	2.28 (3.19%)

Company Info

Industry	Drugstore Chains
Sector	Retail Trade
Employees	315,000
CEO	Ms. Rosalind Gates Brewer

Address	108 Wilmot Road , Deerfield, IL 60015
Phone	1.847.315.3700
Website	www.walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services. The Retail Pharmacy International segment consists of pharmacy-led health and beauty retail businesses and optical practices. The company was founded in 1901 and is headquartered in Deerfield, IL.

Statement Summary

as of 4:00 ET PM 01/13/2022

Total Assets (MRQ)	96.5 B
Total Liabilities (MRQ)	63.1 B
Shareholders’ Equity (MRQ)	33.4 B
Total Revenue (Annual)	33.9 B
Net Income (Annual)	3.6 B

Earnings And Estimates

as of 4:00 ET PM 01/13/2022

Current Qtr EPS Estimate	1.38
Current FY EPS Estimate	5.02
Long Term EPS Growth Estimate	3.39
Next Expected Earnings Date	4/5/2022

WBA vs S&P 500

as of 01/13/2022

	Relative To S&P 500	WBA
4 Weeks	n/a	n/a
12 Weeks	n/a	n/a
YTD	n/a	n/a

Earnings Surprises

as of 4:00 ET PM 01/13/2022

Fiscal Quarter	Estimate	Actual	Surprise
11/2021	1.36	1.68	+23.18%
08/2021	1.04	1.17	+13.04%
05/2021	1.16	1.38	+18.83%
02/2021	1.10	1.26	+14.24%
11/2020	1.03	1.22	+18.58%
08/2020	0.96	1.02	+6.15%
05/2020	1.19	0.83	-29.98%
02/2020	1.46	1.52	+4.20%

Financial Strength

as of 4:00 ET PM 01/13/2022

Pre-Tax Margin	11.25
Net Margin	0.00
Operating Margin	4.06
Return On Equity	25.75
Return On Assets	6.42
Inventory Turnover (TTM)	10.47
Sales Growth (MRQ)	n/a

Ratios

as of 4:00 PM ET 01/13/2022

Price/Earnings (TTM)	7.27
Price/Book (MRQ)	1.79
Price/Cash Flow (TTM)	8.63
Book Value (MRQ)	30.40
Quick Ratio (MRQ)	0.44
Current Ratio (MRQ)	0.83
Total Debt/Equity (MRQ)	1.49

Short Interest

as of 4:00 PM ET 01/14/2022

	% Short - 0.00%
	% Remaining Float - 100.00%

	Current	Last Month
Short Interest Date	n/a	n/a
Short Interest Shares	0	0
Short Interest Ratio	0.0	0.0

M Y M Y

Total Assets 0,0.00 0,0.00

Total Liabilities 0,0.00 0,0.00

Total Equity 0,0.00 0,0.00

M Y M Y

Total Revenue 0,0.00 0,0.00

EBT Exc.
Unusual Items 0,0.00 0,0.00

Net Income 0,0.00 0,0.00

M Y M Y

Cash from
Operations 0,0.00 0,0.00

Cash from
Activities 0,0.00 0,0.00

Cash from
Fin. Activities 0,0.00 0,0.00

Select Period

TOTAL ASSETS	TOTAL LIABILITIES	TOTAL EQUITY

Balance Sheet

	M Y
ASSETS
Cash And Equivalents	0,0.00
Receivables	0,0.00
Inventories	0,0.00
Other Current Assets	0,0.00
Total Current Assets	0,0.00
Property, Plant & Equipment, Gross	0,0.00
Accumulated Depreciation & Depletion	0,0.00
Property, Plant & Equipment, Net	0,0.00
Intangibles	0,0.00
Other Non-Current Assets	0,0.00
Total Non-Current Assets	0,0.00
TOTAL ASSETS	0,0.00
Liabilities & Shareholder Equity
Accounts Payable	0,0.00
Short Term Debt	0,0.00
Total Current Liabilities	0,0.00
Long Term Debt	0,0.00
Deferred Income Taxes	0,0.00
Other Non-Current Liabilities	0,0.00
Minority Interest	0,0.00
Total Non-Current Liabilities	0,0.00
Preferred Stock Equity	0,0.00
Common Stock Equity	0,0.00
Common Par	0,0.00
Additional Paid In Capital	0,0.00
Cumulative Translation Adjustment	0,0.00
Retained Earnings	0,0.00
Treasury Stock	0,0.00
Other Equity Adjustments	0,0.00
Total Capitalization	0,0.00
TOTAL EQUITY	0,0.00
TOTAL LIABILITIES & STOCK EQUITY	0,0.00
Total Common Shares Outstanding	0,0.00
Preferred Shares	0,0.00
Treasury Shares	0,0.00
Basic Weighted Shares Outstanding	0,0.00
Diluted Weighted Shares Outstanding	0,0.00
Number Of Employees	0,0.00
Number Of Part-Time Employees	0,0.00

Select Period

TOTAL REVENUES	EBT Excluding Unusual Items	NET INCOME

Income Statement

	M Y
Sales	0,0.00
Cost Of Sales	0,0.00
Gross Operating Profit	0,0.00
Selling, General, And Administrative Expenses	0,0.00
Research & Development	0,0.00
Operating Income Before D & A (EBITDA)	0,0.00
Depreciation & Amortization	0,0.00
Interest Income	0,0.00
Other Income - Net	0,0.00
Special Income / Charges	0,0.00
Total Income Before Interest Expenses (EBIT)	0,0.00
Interest Expense	0,0.00
Pre-Tax Income	0,0.00
Income Taxes	0,0.00
Minority Interest	0,0.00
Net Income From Continuing Operations	0,0.00
Net Income From Discontinued Operations	0,0.00
Net Income From Total Operations	0,0.00
Extraordinary Income/Losses	0,0.00
Income From Cum. Effect Of Acct. Change	0,0.00
Income From Tax Loss Carryforward	0,0.00
Other Gains / Losses	0,0.00
Total Net Income	0,0.00
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Preferred Dividends	0,0.00
Net Income Available To Common	0,0.00
Basic EPS From Continuing Ops.	0,0.00
Basic EPS From Discontinued Ops.	0,0.00
Basic EPS From Total Operations	0,0.00
Basic EPS From Extraordinary Inc.	0,0.00
Basic EPS From Cum Effect Of Accounting Change	0,0.00
Basic EPS From Tax Loss Carryf'd.	0,0.00
Basic EPS From Other Gains (Losses)	0,0.00
Basic EPS, Total	0,0.00
Basic Normalized Net Income/Share	0,0.00
EPS From Continuing Ops.	0,0.00
EPS From Discontinued Ops	0,0.00
EPS From Total Ops.	0,0.00
EPS From Extraord. Inc.	0,0.00
EPS From Cum Effect of Accounting Change	0,0.00
EPS From Tax Loss Carfd.	0,0.00
EPS From Other Gains (L)	0,0.00
EPS, Total	0,0.00
Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Dividends Paid Per Share	0,0.00

Select Period

CASH FROM OPERATIONS	CASH FROM INVESTING ACTIVITIES	CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

	M Y
Cash Flow From Operating Activities
Net Income (Loss)	0,0.00
Operating Gains/Losses	0,0.00
Gross Operating Profit	0,0.00
(Increase) Decrease In Receivables	0,0.00
(Increase) Decrease In Inventories	0,0.00
(Increase) Decrease In Other Current Assets	0,0.00
(Decrease) Increase In Other Current Liabilities	0,0.00
(Increase) Decrease In Other Working Capital	0,0.00
Other Non-Cash Items	0,0.00
Net Cash From Continuing Operations	0,0.00
Net Cash From Discontinued Operations	0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	0,0.00
Sale Of Property, Plant & Equipment	0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments	0,0.00
Purchases Of Property, Plant & Equipment	0,0.00
Acquisitions	0,0.00
Purchases Of Short-Term Investments	0,0.00
Other Cash From Investing Activities	0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	0,0.00
Issuance Of Debt	0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock	0,0.00
Repayment Of Long-Term Debt	0,0.00
Repurchase Of Capital Stock	0,0.00
Payment Of Cash Dividends	0,0.00
Other Financing Charges, Net	0,0.00
Net Cash From Financing Activities	0,0.00
Effect Of Exchange Rate Changes	0,0.00
Net Change In Cash & Cash Equivalents	0,0.00

Earnings Estimates

as of 4:00 ET PM 01/13/2022

	Current Qtr (02/2022)	Next Qtr (05/2022)
Consensus Estimate	$1.38	$1.08
# of Estimates	19	19
High Estimate	$1.51	$1.34
Low Estimate	$1.24	$0.92
Year Ago EPS	$1.19	$1.38
Year Over Year Growth Estimate	16.41%	-21.85%

	Current Yr (08/2022)	Next Yr (08/2023)
Consensus Estimate	$5.02	$5.15
# of Estimates	20	18
High Estimate	$5.16	$5.30
Low Estimate	$4.86	$4.85
Year Ago EPS	$4.91	$5.02
Year Over Year Growth Estimate	2.31%	2.45%

	Current Qtr (02/2022)	Next Qtr (05/2022)	Current Year (08/2022)	Next Year (08/2023)
Consensus Estimate	$1.38	$1.08	$5.02	$5.15
# of Estimates	19	19	20	18
High Estimate	$1.51	$1.34	$5.16	$5.30
Low Estimate	$1.24	$0.92	$4.86	$4.85
Year Ago EPS	$1.19	$1.38	$4.91	$5.02
Year Over Year Growth Estimate	16.41%	-21.85%	2.31%	2.45%

Insider Information Summary

as of 12/31/1969

	% Insiders - 17.31%
	% Remaining Total Shares - 82.69%

	Current	1 Month
Net Insider Transaction	477.01 K	456.91 K
Shares Bought	608.78 K	608.78 K
Shares Sold	131.77 K	151.87 K

Insider Activity

Purchases

Sales

Options Exercised

Options Awarded

Transaction Date	Insider/Title	Transaction Type	Market Value	Shares	Average Price	Current Holdings

Learn to Trade Like a Pro

Master The Market with the Help of Our Financial Experts

SUBSCRIBE NOW

HEALTH

CVS WBA

By Veronika Bondarenko

Jan 10, 2022 6:50 PM EST

Latest News

Jim Cramer on the Trump Administration's Impact on Walgreens

Jan 6, 2022 3:06 PM EST

Closing Bell: Wall Street Closes in Red as Financial, Energy Sectors Drag Stocks Lower

Jan 6, 2022 6:50 AM EST

More than 210 Chinese firms with a combined market capitalisation of about US$2.2 trillion were listed on major US stock exchanges as of October. Photo: AFP

Jan 5, 2022 7:32 PM EST

Theranos Founder Elizabeth Holmes Indicted on Fraud Charges

Jan 4, 2022 2:51 PM EST

Dec 31, 2021 8:41 AM EST

Dec 22, 2021 9:57 AM EST

Jim Cramer Is Watching Walgreens and Rite Aid Earnings Next Week

Dec 21, 2021 2:23 PM EST

Dec 10, 2021 2:00 PM EST

Dec 8, 2021 7:00 AM EST

Nov 23, 2021 6:53 PM EST

Nov 18, 2021 12:20 PM EST

Nov 16, 2021 11:25 AM EST

Is the Stock Market Open or Closed on Veterans Day 2019?

Nov 11, 2021 6:17 AM EST

Stocks Close Higher as Wall Street Dissects New Tax Laws

Oct 14, 2021 2:08 PM EDT

Traders work the floor of the New York Stock Exchange during the IPO of Chinese cosmetics company Yatsen Holding Ltd on November 19. Photo: NYSE via AP

Oct 14, 2021 7:30 AM EDT

Oct 14, 2021 7:11 AM EDT

Oct 14, 2021 6:08 AM EDT

Oct 11, 2021 6:02 AM EDT

S&P 500 Overvalued But Still Better Than Small Caps or Bonds

Oct 8, 2021 7:02 PM EDT

Oct 6, 2021 1:49 PM EDT

Sep 15, 2021 2:17 PM EDT

Sep 15, 2021 1:11 PM EDT

Midday Report: Walmart Does Heavy Lifting on S&P 500; AthenaHealth Boosts Nasdaq

Sep 9, 2021 11:15 AM EDT

Sep 2, 2021 4:41 PM EDT

Recent Articles from TheStreet

Elon Musk, founder of Tesla and SpaceX, brought attention on the Clubhouse to new heights after hosting a conversation on the audio social app. Photo: AFP

INVESTING

TSLA

A Tesla lawyer asked law firm Cooley to fire an attorney who worked on a U.S. Securities and Exchange Commission investigation of Elon Musk, according to a Wall Street Journal report.